KR100820657B1 - 인지질의 제조법 - Google Patents
인지질의 제조법 Download PDFInfo
- Publication number
- KR100820657B1 KR100820657B1 KR1020037001560A KR20037001560A KR100820657B1 KR 100820657 B1 KR100820657 B1 KR 100820657B1 KR 1020037001560 A KR1020037001560 A KR 1020037001560A KR 20037001560 A KR20037001560 A KR 20037001560A KR 100820657 B1 KR100820657 B1 KR 100820657B1
- Authority
- KR
- South Korea
- Prior art keywords
- phospholipid
- homogenization
- reaction
- mixture
- producing
- Prior art date
Links
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 190
- 238000002360 preparation method Methods 0.000 title description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 73
- 239000000203 mixture Substances 0.000 claims abstract description 70
- 238000000265 homogenisation Methods 0.000 claims abstract description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 66
- 238000004519 manufacturing process Methods 0.000 claims abstract description 51
- 238000000034 method Methods 0.000 claims abstract description 35
- 239000004976 Lyotropic liquid crystal Substances 0.000 claims abstract description 31
- 108090000553 Phospholipase D Proteins 0.000 claims abstract description 30
- 239000003960 organic solvent Substances 0.000 claims abstract description 28
- 125000001095 phosphatidyl group Chemical group 0.000 claims abstract description 26
- 238000006276 transfer reaction Methods 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 23
- 102000011420 Phospholipase D Human genes 0.000 claims abstract description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 10
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 110
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 110
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 41
- 229960001153 serine Drugs 0.000 claims description 37
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 20
- 235000019441 ethanol Nutrition 0.000 claims description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 13
- 239000002184 metal Substances 0.000 claims description 13
- 229960005070 ascorbic acid Drugs 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 150000001298 alcohols Chemical class 0.000 claims description 7
- 239000008157 edible vegetable oil Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 5
- 239000002211 L-ascorbic acid Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 229960001031 glucose Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229910003002 lithium salt Inorganic materials 0.000 claims description 3
- 159000000002 lithium salts Chemical class 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 159000000001 potassium salts Chemical class 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 22
- 239000011575 calcium Substances 0.000 abstract description 22
- 229910052791 calcium Inorganic materials 0.000 abstract description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 45
- 239000002244 precipitate Substances 0.000 description 26
- 238000005191 phase separation Methods 0.000 description 23
- 229960005069 calcium Drugs 0.000 description 21
- 239000007795 chemical reaction product Substances 0.000 description 21
- 239000007864 aqueous solution Substances 0.000 description 19
- 239000012071 phase Substances 0.000 description 18
- MFYYKSHXSCXFEA-UHFFFAOYSA-N 1-dodecyl-3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-1-ium-4-carbaldehyde;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC(CO)=C(C=O)C(O)=C1C MFYYKSHXSCXFEA-UHFFFAOYSA-N 0.000 description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 16
- 235000013305 food Nutrition 0.000 description 13
- 239000001110 calcium chloride Substances 0.000 description 12
- 229910001628 calcium chloride Inorganic materials 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- -1 phosphatidyl ascorbic acid Chemical compound 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 8
- 229960002715 nicotine Drugs 0.000 description 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 239000004973 liquid crystal related substance Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000220259 Raphanus Species 0.000 description 6
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 5
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 5
- 235000014121 butter Nutrition 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 239000000693 micelle Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 4
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 229940083466 soybean lecithin Drugs 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000008347 soybean phospholipid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 240000007124 Brassica oleracea Species 0.000 description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 235000019486 Sunflower oil Nutrition 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 3
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 235000001046 cacaotero Nutrition 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000001727 glucose Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002600 sunflower oil Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 230000002535 lyotropic effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical group CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- NSFXVRRBGNORBD-UHFFFAOYSA-N 2h-benzo[f]benzotriazole Chemical compound C1=C2C=CC=CC2=CC2=NNN=C21 NSFXVRRBGNORBD-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- SFGGITYAMFZATC-UHFFFAOYSA-N ClC(Cl)Cl.CC(C)CC(C)(C)C Chemical compound ClC(Cl)Cl.CC(C)CC(C)(C)C SFGGITYAMFZATC-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- NPAGFLVMYDKFJH-UHFFFAOYSA-N dichloromethane;2,2,4-trimethylpentane Chemical compound ClCCl.CC(C)CC(C)(C)C NPAGFLVMYDKFJH-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002120 nanofilm Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008349 purified phosphatidyl choline Substances 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6481—Phosphoglycerides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
세린/인지질(몰비) | 1 | 5 | ||
칼슘 첨가 | 무 | 유 | 무 | 유 |
NATHIN 250 (g) | 10 | 10 | 10 | 10 |
세린 (g) | 0.8 | 0.8 | 4.0 | 4.0 |
염화칼슘 (g) | - | 0.04 | - | 0.19 |
물 (g) | 2.6 | 2.6 | 5.7 | 5.7 |
PLD-Y1 (units) | 82.2 | 82.2 | 82.2 | 82.2 |
세린/인지질(몰비) | 1 | 5 | ||
칼슘 첨가 | 무 | 유 | 무 | 유 |
PA (몰%) | 13.0 | 11.8 | 10.9 | 11.0 |
PE (몰%) | 4.7 | 3.3 | 3.2 | 2.7 |
PS (몰%) | 34.5 | 35.5 | 44.2 | 47.4 |
PC (몰%) | 31.0 | 32.2 | 25.0 | 21.4 |
기타 인지질(몰%) | 16.9 | 17.1 | 16.7 | 17.5 |
세린/인지질 (몰비) | 5 | |
칼슘 첨가 | 무 | 유 |
NATHIN 250 아세톤침전물 (g) | 6.0 | 6.0 |
세린 (g) | 2.4 | 2.4 |
염화칼슘 (g) | - | 0.1 |
물 (g) | 3.4 | 3.4 |
PLD-Y1 (units) | 49.3 | 49.3 |
세린/인지질 (몰비) | 5 | |
칼슘 첨가 | 무 | 유 |
PA (몰%) | 9.0 | 10.2 |
PE (몰%) | 2.7 | 1.9 |
PS (몰%) | 35.1 | 41.7 |
PC (몰%) | 35.3 | 28.8 |
기타 인지질 (몰%) | 17.9 | 17.4 |
사용한 수용체 | 수용액 농도 %(W/W) | pH | 수용체 전이 레시틴 생성율(%) |
글리세롤 | 50 | 5.9 | 42.7 |
L-아스코르빈산 | 41 | 5.0 | 9.4 |
아스코르빈산 인산에스테르 마그네슘염 | 17 | 6.7 | 0.0 |
아스코르빈산 인산에스테르 나트륨염 | 50 | 7.0 | 0.0 |
이노시톨 | 17 | 6.5 | 0.0 |
글루코오스 | 50 | 5.0 | 13.3 |
트레할로스 | 50 | 5.3 | 0.0 |
식염첨가량 (m ㏖/g 인지질) | 침전획분으로의 PS 회수율(%) | 침전 인지질중 PS함량(%) | 상청 인지질중 PS함량(%) |
무첨가 0.05 0.15 0.25 0.50 1.25 2.5 5 10 25 50 | - 53.7 73.8 80.4 96.2 97.4 96.6 97.1 95.7 97.8 97.7 | - 64.7 66.7 69.3 63.8 63.5 62.7 59.8 55.0 47.2 46.6 | 43.2 33.4 28.2 18.0 6.2 4.3 6.1 6.4 10.5 12.0 13.5 |
Claims (11)
- 포스파티딜기 전이반응을 이용해서 인지질을 제조하는 방법에 있어서, 원료 인지질과, 수산기를 갖는 수용체와, 포스포리파제D와, 원료 인지질에 대하여 10중량%~100중량%의 물을, 유기용매의 부존재하에서 혼합하고, 또한 균질화 처리에 회부함으로써 균질화 혼합물을 얻는 균질화 공정; 및얻어진 균질화 혼합물을 15℃∼65℃에서 반응시키는 반응공정을 구비한 것을 특징으로 하는 인지질의 제조법.
- 제1항에 있어서, 상기 균질화 공정에 있어서 얻어지는 균질화 혼합물이, 라멜라형 리오트로픽 액정구조를 갖는 것을 특징으로 하는 인지질의 제조법.
- 삭제
- 제1항 또는 제2항에 있어서, 상기 균질화 공정에 있어서의 수산기를 갖는 수용체의 첨가량이, 원료 인지질 1몰에 대하여 0.3몰∼10몰인 것을 특징으로 하는 인지질의 제조법.
- 제1항 또는 제2항에 있어서, 상기 수산기를 갖는 수용체가, 세린, 글리세롤, L-아스코르빈산, 글루코오스 및 콜린으로부터 선택되는 1종 또는 2종 이상인 것을 특징으로 하는 인지질의 제조법.
- 제1항 또는 제2항에 있어서, 상기 수산기를 갖는 수용체가 세린이고, 생성되는 인지질이 포스파티딜세린인 것을 특징으로 하는 인지질의 제조법.
- 제1항 또는 제2항에 있어서, 상기 균질화 공정에 있어서의 균질화 처리시에, 식용유지를 더 첨가하는 것을 특징으로 하는 인지질의 제조법.
- 제6항에 있어서,얻어진 포스파티딜세린을 함유하는 인지질 혼합물을 알콜류에 용해하는 용해 공정; 및상기 용해액중에 금속염을 첨가함으로써 포스파티딜세린을 불용화시키고, 그 불용부를 분리하는 불용화공정을 더 구비한 것을 특징으로 하는 인지질의 제조법.
- 제8항에 있어서, 상기 금속염으로서, 리튬염, 칼륨염 및 나트륨염으로부터 선택되는 1종 또는 2종 이상을 사용하는 것을 특징으로 하는 인지질의 제조법.
- 제8항에 있어서, 상기 금속염으로서, 염화리튬, 염화칼륨 또는 염화나트륨을 사용하는 것을 특징으로 하는 인지질의 제조법.
- 제8항에 있어서, 상기 알콜류로서 에틸알콜을 사용하는 것을 특징으로 하는 인지질의 제조법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000241034A JP4298902B2 (ja) | 2000-08-09 | 2000-08-09 | リン脂質の製造法 |
JPJP-P-2000-00241034 | 2000-08-09 | ||
PCT/JP2001/006502 WO2002012532A1 (fr) | 2000-08-09 | 2001-07-27 | Processus de production de phospholipides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030033014A KR20030033014A (ko) | 2003-04-26 |
KR100820657B1 true KR100820657B1 (ko) | 2008-04-10 |
Family
ID=18732297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037001560A KR100820657B1 (ko) | 2000-08-09 | 2001-07-27 | 인지질의 제조법 |
Country Status (13)
Country | Link |
---|---|
US (3) | US20030148477A1 (ko) |
EP (1) | EP1310563B1 (ko) |
JP (1) | JP4298902B2 (ko) |
KR (1) | KR100820657B1 (ko) |
CN (1) | CN1318598C (ko) |
AT (1) | ATE435298T1 (ko) |
AU (1) | AU2002229150A1 (ko) |
BR (1) | BR0113132B1 (ko) |
CA (1) | CA2417597C (ko) |
DE (1) | DE60139129D1 (ko) |
ES (1) | ES2328014T3 (ko) |
IL (2) | IL154218A0 (ko) |
WO (1) | WO2002012532A1 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004107875A1 (ja) * | 2003-06-06 | 2004-12-16 | Nagase Chemtex Corporation | リン脂質含有乳化性組成物 |
DE102004002053A1 (de) * | 2004-01-15 | 2005-08-04 | Bioghurt Biogarde Gmbh & Co. Kg | Verfahren zur Herstellung von Phosphatidylserin und dessen Reinigung durch Extraktion |
US20050158835A1 (en) * | 2004-01-21 | 2005-07-21 | Su Chen | Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid |
ITPD20050164A1 (it) | 2005-05-30 | 2006-11-30 | Fidia Farmaceutici | Processo per la preparazione e l'isolamento di fosfatidi |
KR101122388B1 (ko) * | 2009-05-23 | 2012-03-23 | 주식회사 고센바이오텍 | 배추 포스포리파아제 d에 의한 난황 인지질로부터 포스파티딜세린의 생합성 방법 |
KR101055094B1 (ko) * | 2009-05-23 | 2011-08-08 | 주식회사 고센바이오텍 | 양배추 포스포리파아제 d에 의한 난황 인지질로부터 포스파티딜세린의 생합성 방법 |
CN103555783B (zh) * | 2013-10-24 | 2015-08-12 | 陕西源邦生物技术有限公司 | 一种制备磷脂酰丝氨酸的方法 |
CN104327114A (zh) * | 2014-11-06 | 2015-02-04 | 江南大学 | 一种磷脂酰丝氨酸的制备方法 |
CN109628517A (zh) * | 2018-12-27 | 2019-04-16 | 南通励成生物工程有限公司 | 一种超声波辅助酶解制备磷脂酰丝氨酸的方法 |
CN111534375B (zh) * | 2020-05-26 | 2022-02-08 | 内蒙古铂贝曼科技有限公司 | 一种含水磷脂弹性体的制备方法 |
WO2022227248A1 (zh) * | 2021-04-27 | 2022-11-03 | 内蒙古铂贝曼科技有限公司 | 一种活性磷脂层状液晶及其制备工艺与应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2657274B2 (ja) * | 1987-04-21 | 1997-09-24 | 株式会社ヤクルト本社 | リン脂質の製造法 |
US5900409A (en) | 1994-11-08 | 1999-05-04 | Kabushiki Kaisha Yakult Honsha | Cerebration improver |
JP2942302B2 (ja) * | 1990-04-10 | 1999-08-30 | 株式会社ヤクルト本社 | ホスファチジルアスコルベート、その製造方法、乳化剤、過酸化脂質抑制剤及び化粧料 |
JP2981294B2 (ja) * | 1991-02-22 | 1999-11-22 | 花王株式会社 | ホスファチジン酸の製造方法 |
JP3291289B2 (ja) * | 2000-01-19 | 2002-06-10 | サンユレック株式会社 | 電子部品の製造方法 |
US6492146B1 (en) | 1999-04-28 | 2002-12-10 | Chemi S.P.A. | Process for the preparation of phosphatidylserines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0716426B2 (ja) * | 1986-08-01 | 1995-03-01 | 日本油脂株式会社 | 酵素によるリン脂質の製造方法 |
US5733892A (en) * | 1990-07-24 | 1998-03-31 | Seikagaku Corporation | Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same |
JP3791951B2 (ja) * | 1995-11-08 | 2006-06-28 | 株式会社ヤクルト本社 | 多価不飽和脂肪酸含有ホスファチジルセリンを含む油脂組成物の製造方法 |
ATE287448T1 (de) * | 1999-06-15 | 2005-02-15 | Yissum Res Dev Co | Enzymatische herstellung von phospholipiden in wässrigen medien |
-
2000
- 2000-08-09 JP JP2000241034A patent/JP4298902B2/ja not_active Expired - Lifetime
-
2001
- 2001-07-27 EP EP01984491A patent/EP1310563B1/en not_active Expired - Lifetime
- 2001-07-27 CN CNB018170919A patent/CN1318598C/zh not_active Expired - Fee Related
- 2001-07-27 AU AU2002229150A patent/AU2002229150A1/en not_active Abandoned
- 2001-07-27 AT AT01984491T patent/ATE435298T1/de active
- 2001-07-27 KR KR1020037001560A patent/KR100820657B1/ko not_active IP Right Cessation
- 2001-07-27 IL IL15421801A patent/IL154218A0/xx unknown
- 2001-07-27 WO PCT/JP2001/006502 patent/WO2002012532A1/ja active Application Filing
- 2001-07-27 DE DE60139129T patent/DE60139129D1/de not_active Expired - Lifetime
- 2001-07-27 BR BRPI0113132-0A patent/BR0113132B1/pt not_active IP Right Cessation
- 2001-07-27 US US10/344,063 patent/US20030148477A1/en not_active Abandoned
- 2001-07-27 ES ES01984491T patent/ES2328014T3/es not_active Expired - Lifetime
- 2001-07-27 CA CA002417597A patent/CA2417597C/en not_active Expired - Fee Related
-
2003
- 2003-01-30 IL IL154218A patent/IL154218A/en not_active IP Right Cessation
-
2005
- 2005-02-24 US US11/065,974 patent/US20050170476A1/en not_active Abandoned
-
2007
- 2007-01-17 US US11/654,192 patent/US7695944B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2657274B2 (ja) * | 1987-04-21 | 1997-09-24 | 株式会社ヤクルト本社 | リン脂質の製造法 |
JP2942302B2 (ja) * | 1990-04-10 | 1999-08-30 | 株式会社ヤクルト本社 | ホスファチジルアスコルベート、その製造方法、乳化剤、過酸化脂質抑制剤及び化粧料 |
JP2981294B2 (ja) * | 1991-02-22 | 1999-11-22 | 花王株式会社 | ホスファチジン酸の製造方法 |
US5900409A (en) | 1994-11-08 | 1999-05-04 | Kabushiki Kaisha Yakult Honsha | Cerebration improver |
US6492146B1 (en) | 1999-04-28 | 2002-12-10 | Chemi S.P.A. | Process for the preparation of phosphatidylserines |
JP3291289B2 (ja) * | 2000-01-19 | 2002-06-10 | サンユレック株式会社 | 電子部品の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1310563B1 (en) | 2009-07-01 |
CN1318598C (zh) | 2007-05-30 |
BR0113132A (pt) | 2003-07-15 |
IL154218A0 (en) | 2003-07-31 |
ATE435298T1 (de) | 2009-07-15 |
US20030148477A1 (en) | 2003-08-07 |
BR0113132B1 (pt) | 2012-03-06 |
JP4298902B2 (ja) | 2009-07-22 |
CA2417597A1 (en) | 2003-01-28 |
AU2002229150A1 (en) | 2002-02-18 |
DE60139129D1 (de) | 2009-08-13 |
EP1310563A4 (en) | 2008-03-12 |
JP2002051794A (ja) | 2002-02-19 |
US20070134776A1 (en) | 2007-06-14 |
CA2417597C (en) | 2007-06-26 |
WO2002012532A1 (fr) | 2002-02-14 |
US20050170476A1 (en) | 2005-08-04 |
KR20030033014A (ko) | 2003-04-26 |
ES2328014T3 (es) | 2009-11-06 |
IL154218A (en) | 2008-07-08 |
CN1468314A (zh) | 2004-01-14 |
US7695944B2 (en) | 2010-04-13 |
EP1310563A1 (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7695944B2 (en) | Method for producing phosholipid | |
KR100941899B1 (ko) | 아스타산틴 중쇄 지방산 에스테르, 그 제조법, 및 이들을함유하는 조성물 | |
JP4933432B2 (ja) | 新規なリン脂質加工剤 | |
JP2007259866A (ja) | ホスファチドの製造と使用 | |
EP1740708B1 (en) | Enzymatic production of hydrolyzed lecithin products | |
EP0147699A2 (fr) | Produit alimentaire efficace dans le traitement de la lépre | |
AU2007205762B2 (en) | Process for the production of phospholipids | |
US8637278B2 (en) | Method for the enzymatic production of emulsifiers containing mono- and diacylglycerides | |
JPH0387191A (ja) | ホスファチジルイノシトールの製造方法 | |
JP2001186898A (ja) | 多価不飽和脂肪酸残基をもつホスファチジルセリンの製造法 | |
JP5041790B2 (ja) | 多価不飽和脂肪酸を構成要素とするホスファチジルセリンの製造方法 | |
KR101949741B1 (ko) | 피놀렌산 고함유 모노갈락토실디아실글리세롤 제조방법 | |
JP4327943B2 (ja) | 改質油脂組成物の製造法 | |
JPH0253726A (ja) | コレステロール低下剤および新規リン脂質 | |
JPH0684382B2 (ja) | 水分散性の良いレシチン | |
JP2008092871A (ja) | ホスファチジルセリンの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20030203 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060629 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070329 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20080314 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20080402 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20080403 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20110318 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20120322 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20130321 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20130321 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140319 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20140319 Start annual number: 7 End annual number: 7 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20160309 |